CellaVision AB (publ)
CLVSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $176 | $191 | $195 | $187 |
| % Growth | -8.2% | -1.8% | 4.3% | – |
| Cost of Goods Sold | $54 | $62 | $58 | $58 |
| Gross Profit | $121 | $130 | $137 | $129 |
| % Margin | 69.1% | 67.7% | 70.4% | 69.2% |
| R&D Expenses | $29 | $22 | $25 | $20 |
| G&A Expenses | $20 | $24 | $23 | $22 |
| SG&A Expenses | $53 | $57 | $56 | $58 |
| Sales & Mktg Exp. | $33 | $33 | $33 | $35 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $82 | $79 | $80 | $78 |
| Operating Income | $40 | $50 | $57 | $51 |
| % Margin | 22.5% | 26.3% | 29.3% | 27.5% |
| Other Income/Exp. Net | -$0 | -$2 | -$5 | $0 |
| Pre-Tax Income | $39 | $48 | $53 | $51 |
| Tax Expense | $8 | $10 | $11 | $11 |
| Net Income | $31 | $38 | $42 | $41 |
| % Margin | 17.8% | 19.7% | 21.3% | 21.9% |
| EPS | 1.31 | 1.58 | 1.74 | 1.72 |
| % Growth | -17.1% | -9.2% | 1.2% | – |
| EPS Diluted | 1.31 | 1.58 | 1.74 | 1.72 |
| Weighted Avg Shares Out | 24 | 24 | 24 | 24 |
| Weighted Avg Shares Out Dil | 24 | 24 | 24 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2 | $1 | $3 |
| Interest Expense | $0 | $4 | $5 | $3 |
| Depreciation & Amortization | $0 | $0 | $0 | $10 |
| EBITDA | $40 | $52 | $58 | $64 |
| % Margin | 22.6% | 27.2% | 29.6% | 34.2% |